Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001567619-21-014512)

Filing Details

Accession Number:
0001567619-21-014512
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-05 17:01:38
Reporting Period:
2021-08-03
Accepted Time:
2021-08-05 17:01:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874716 Idexx Laboratories Inc IDXX In Vitro & In Vivo Diagnostic Substances (2835) 010393723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740689 Michael Lane C/O Idexx Laboratories, Inc.
One Idexx Drive
Westbrook ME 04092		 Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-03 1,472 $67.85 5,119 No 4 M Direct
Common Stock Acquisiton 2021-08-03 1,091 $67.85 6,210 No 4 M Direct
Common Stock Acquisiton 2021-08-03 4,436 $141.60 10,646 No 4 M Direct
Common Stock Disposition 2021-08-03 2,451 $690.20 8,195 No 4 S Direct
Common Stock Disposition 2021-08-03 250 $691.54 7,945 No 4 S Direct
Common Stock Disposition 2021-08-03 363 $692.85 7,582 No 4 S Direct
Common Stock Disposition 2021-08-03 1,447 $693.73 6,135 No 4 S Direct
Common Stock Disposition 2021-08-03 916 $694.79 5,219 No 4 S Direct
Common Stock Disposition 2021-08-03 100 $695.50 5,119 No 4 S Direct
Common Stock Disposition 2021-08-03 95 $687.47 5,024 No 4 S Direct
Common Stock Disposition 2021-08-03 245 $688.54 4,779 No 4 S Direct
Common Stock Disposition 2021-08-03 245 $689.43 4,534 No 4 S Direct
Common Stock Disposition 2021-08-03 30 $690.33 4,504 No 4 S Direct
Common Stock Disposition 2021-08-03 100 $691.35 4,404 No 4 S Direct
Common Stock Disposition 2021-08-03 60 $692.65 4,344 No 4 S Direct
Common Stock Disposition 2021-08-03 84 $687.59 4,280 No 4 S Direct
Common Stock Disposition 2021-08-03 299 $688.51 3,961 No 4 S Direct
Common Stock Disposition 2021-08-03 153 $689.51 3,808 No 4 S Direct
Common Stock Disposition 2021-08-03 100 $691.19 3,708 No 4 S Direct
Common Stock Disposition 2021-08-03 60 $692.56 3,648 No 4 S Direct
Common Stock Disposition 2021-08-03 1 $693.17 3,647 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right-to-buy) Disposition 2021-08-03 1,472 $0.00 1,472 $67.85
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2021-08-03 1,091 $0.00 1,091 $67.85
Common Stock Non-Qualified Stock Option (right-to-buy) Disposition 2021-08-03 4,436 $0.00 4,436 $141.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
462 2026-02-13 No 4 M Direct
0 2026-02-13 No 4 M Direct
1,512 2027-02-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 592 Indirect by spouse
Footnotes
  1. Includes a total of 23.2845 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021.
  2. Represents the weighted average sales price of the shares sold ranging from a low of $690.00 to a high of $690.965 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average sales price of the shares sold ranging from a low of $691.085 to a high of $692.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  4. Represents the weighted average sales price of the shares sold ranging from a low of $692.33 to a high of $693.26 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  5. Represents the weighted average sales price of the shares sold ranging from a low of $693.38 to a high of $694.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  6. Represents the weighted average sales price of the shares sold ranging from a low of $694.49 to a high of $695.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  7. Represents the weighted average sales price of the shares sold ranging from a low of $686.91 to a high of $687.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  8. Represents the weighted average sales price of the shares sold ranging from a low of $688.07 to a high of $688.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  9. Represents the weighted average sales price of the shares sold ranging from a low of $689.14 to a high of $690 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  10. Represents the weighted average sales price of the shares sold ranging from a low of $690.17 to a high of $690.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  11. Represents the weighted average sales price of the shares sold ranging from a low of $691.19 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  12. Represents the weighted average sales price of the shares sold ranging from a low of $692.27 to a high of $692.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  13. Represents the weighted average sales price of the shares sold ranging from a low of $687.05 to a high of $687.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  14. Represents the weighted average sales price of the shares sold ranging from a low of $688.09 to a high of $688.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  15. Represents the weighted average sales price of the shares sold ranging from a low of $689.25 to a high of $690.18 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  16. Represents the weighted average sales price of the shares sold ranging from a low of $690.45 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  17. Represents the weighted average sales price of the shares sold ranging from a low of $692.125 to a high of $692.85 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  18. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
  19. Grant of option to buy 2,072 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
  20. Grant of option to buy 10,749 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017.
  21. Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018.
  22. Not applicable.
Insider Monkey Quarterly Strategy
+246.9% Insider Monkey Quarterly Strategy
+107.5% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
200%
100%
0
Subscribe Now

Returns since its inception in May 2014 (through Feb 16th, 2024)